In recent years, use of new weight-loss medications has risen in the United States. A 2026 Gallup poll found that a record 11% of U.S. adults are taking GLP-1 medications for weight loss, up from 3% in 2024. Furthermore, high-profile figures like Illinois Gov. JB Pritzker (D) and decorated tennis player Serena Williams have extolled their experiences taking the drug. The rising prevalence of GLP-1 use for weight management has sparked a debate over their potential impact on health and wellness in the U.S.
Ad-free podcasts are here!
Get 20% off your first year of ad-free episodes, exclusive interviews, and deep dives with Tangle’s podcast membership!
It’s a Big Apple episode for apple season. On the most recent Suspension of the Rules, Isaac, Ari, and Kmele talk about the ongoing UN assembly in New York. Then, a discussion of a New York Times Magazine article about public schooling and race. Plus, guess who has a complaint about leaves? (hint: Kmele. It’s Kmele.) Check it out here.
You can read today's podcast here and today’s “Have a nice day” story here.
You can subscribe to Tangle by clicking here or drop something in our tip jar by clicking here.
Take the survey: What is your relationship to GLP-1s? Let us know.
Our Executive Editor and Founder is Isaac Saul. Our Executive Producer is Jon Lall.
This podcast written by: Audrey Moorehead and audio engineered and edited by Dewey Thomas. Music for the podcast was produced by Diet 75.
Our newsletter is edited by Managing Editor Ari Weitzman, Senior Editor Will Kaback, Bailey Saul, Audrey Moorehead, and Carina Pacheco.
","author_name":"Isaac Saul"}